-
Munc18c–Syntaxin4 Control of Tumor Cell Invasion
2026-08-20
The reference study identifies Munc18c as a functional regulator of syntaxin4 during invadopodium formation, linking SNARE-mediated membrane trafficking with extracellular matrix invasion. Its combination of interaction assays, targeted peptide interference, imaging, and trafficking measurements provides a mechanistic framework for studying how MT1-MMP and EGFR reach invasive tumor-cell membranes.
-
Plerixafor (AMD3100): A Platelet–Tumor Axis Lens
2026-08-20
Plerixafor (AMD3100) is more than a CXCR4 inhibitor for routine migration assays. This article explains how CXCL12 compartmentalization and platelet extravasation reshape experimental design for cancer metastasis inhibition, stem cell mobilization, and immune-cell trafficking research.
-
Recombinant Mouse Sonic Hedgehog Workflow Guide
2026-08-19
Build more controlled developmental assays with Recombinant Mouse Sonic Hedgehog, from alkaline phosphatase induction to genital-tubercle explant studies. The workflow connects dose-defined SHH protein exposure with comparative mouse–guinea pig evidence for studying morphogenesis and congenital malformation research.
-
Pioglitazone Workflows for PPARγ Research
2026-08-19
Pioglitazone enables controlled studies of PPARγ-dependent metabolism, macrophage polarization, and inflammatory signaling. This workflow-centered guide connects cell assays with DSS-induced intestinal inflammation while addressing solubility, controls, readouts, and cross-model interpretation.
-
Dimetridazole: From QS Signals to Assay Design
2026-08-18
Dimetridazole (1,2-Dimethyl-5-nitroimidazole) is best studied as a context-dependent antimicrobial and antivirulence tool. This article translates quorum-sensing, transcriptomic, combination, and infection-model evidence into a practical assay strategy.
-
A1 Versus AMD3100 in Colorectal Cancer
2026-08-18
Khorramdelazad and colleagues evaluated the fluorinated CXCR4 inhibitor A1 against AMD3100 using molecular simulations, CT-26 cell assays, and a BALB/c colorectal cancer model. A1 showed stronger computed receptor interactions and greater suppression of tumor growth, migration, regulatory T-cell infiltration, and immunosuppressive signaling, although the findings remain preclinical.
-
Dimetridazole: From Antimicrobial to Antivirulence
2026-08-17
Dimetridazole, also known as 1,2-Dimethyl-5-nitroimidazole, is gaining renewed interest as a research tool for connecting antimicrobial activity with quorum sensing, virulence control, biofilm formation suppression, and combination therapy. This thought-leadership analysis explains how to translate its strain-dependent biology into rigorous bacterial culture assays and infection model research without overstating the evidence.
-
EZ Cap EGFP mRNA 5-moUTP Workflow
2026-08-17
Use EZ Cap EGFP mRNA 5-moUTP as a bright, transient benchmark for delivery, translation, viability, and imaging studies. Its Cap1 structure, 5-moUTP chemistry, and approximately 100-nucleotide poly(A) tail help separate RNA-quality problems from vector, uptake, and intracellular-release limitations.
-
Leupeptin Hemisulfate Salt for Reliable Assays
2026-08-16
This scenario-based guide explains how Leupeptin, Microbial (Leupeptin hemisulfate), SKU A2570, can improve protease activity regulation and interpretation of cell-based and biochemical assays. It covers formulation, compatibility, preparation, controls, vendor selection, and limitations relevant to viability, proliferation, cytotoxicity, autophagy, and viral replication studies.
-
HyperScript™ Reverse Transcriptase for Assay Design
2026-08-15
Discover how HyperScript™ Reverse Transcriptase improves RNA to cDNA conversion when template structure, limited input, and transcript length challenge RT-qPCR. This article connects enzyme selection with target-specific assay architecture using recent Moloney murine leukemia virus research.
-
Heat-Not-Burn Products: Genotoxicity Evidence
2026-08-14
The 2024 reference study compared a heat-not-burn product with conventional cigarettes using complementary rat and in vitro genetic-toxicology models. Its integrated design found lower cytotoxicity and genotoxicity signals for the heat-not-burn product under the tested conditions, while also showing why reduced toxicant production should not be equated with absence of biological risk.
-
Cannabidiol and Orofacial Inflammatory Pain
2026-08-14
The reference study shows that cannabidiol reduces both nociceptive and pain-related affective abnormalities in mouse models through distinct peripheral and central mechanisms. Its combination of behavioral, molecular, and fiber-photometry analyses provides a useful framework for evaluating therapies that target sensory pain together with anxiety, depressive-like behavior, and cognitive impairment.
-
Netarsudil (AR-13324): Mechanism and Evidence
2026-08-13
Netarsudil, also called AR-13324, is a selective Rho kinase inhibitor that changes trabecular meshwork cell architecture and supports aqueous humor outflow regulation. A 2026 study also identified netarsudil as an ionizable drug candidate for siRNA nanoparticle codelivery, but that application remains an experimental formulation strategy.
-
Sabutoclax Workflows for Apoptosis Assays
2026-08-13
Sabutoclax is a permeable pan-Bcl-2 inhibitor for separating growth arrest from genuine cell killing in cancer models. This guide connects dose-response design, orthogonal apoptosis measurements, model selection, and troubleshooting to improve reproducibility from cultured cells to a prostate cancer xenograft model.
-
Polymyxin B Sulfate: Research Workflows
2026-08-12
Use Polymyxin B sulfate as a membrane-active comparator in multidrug-resistant Gram-negative infection studies, while preserving a separate path for immune-cell assays. This workflow connects phenotypic susceptibility testing with carbapenemase-gene location, plasmid transfer, clonality, and carefully controlled dendritic cell readouts.